The role of programmed death 1 (PD-1) receptor, its ligands PD-L1 and PD-L2, and IL-10 in LP-BM5 induced MAIDS

被引：0
|
作者：
Green, KA
Okazaki, T
Honjo, T
Green, WR
机构：
[1] Dartmouth Coll Sch Med, Lebanon, NH 03756 USA
[2] Kyoto Univ, Sakyo Ku, Kyoto 6068501, Japan
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A963 / A963
页数：1
相关论文
共 50 条
  • [11] Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell Disorders
    Xu, Jie
    Sun, Heather H.
    Fletcher, Christopher D. M.
    Hornick, Jason L.
    Morgan, Elizabeth A.
    Freeman, Gordon J.
    Hodi, F. Stephen
    Pinkus, Geraldine S.
    Rodig, Scott J.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (04) : 443 - 453
  • [12] Altered Expression of Immune Checkpoint Molecules Including Programmed Cell Death-1 (PD-1) and Its Ligands PD-L1/PD-L2 in Waldenstrom's Macroglobulinemia
    Jalali, Shahrzad
    Price-Troska, Tammy
    Novak, Anne J.
    Ansell, Stephen M.
    BLOOD, 2016, 128 (22)
  • [13] The PD-1 pathway in systemic lupus erythematosus: The Ligands of PD-1, PD-L1 and PD-L2, are also susceptibility factors.
    Abelson, AK
    Johansson, C
    Kozyrev, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S203 - S203
  • [14] PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
    Ghiotto, Marguerite
    Gauthier, Laurent
    Serriari, Nacer
    Pastor, Sonia
    Truneh, Alemseged
    Nunes, Jacques A.
    Olive, Daniel
    INTERNATIONAL IMMUNOLOGY, 2010, 22 (08) : 651 - 660
  • [15] PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer
    Yang, Shijie
    Zhang, Qiuyang
    Liu, Sen
    Wang, Alun R.
    You, Zongbing
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2016, 4 (01): : 1 - 8
  • [16] PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis
    Carter, Laura L.
    Leach, Michael W.
    Azoitei, Mihai L.
    Cui, Junqing
    Pelker, Jeffrey W.
    Jussif, Jason
    Benoit, Steve
    Ireland, Gretchen
    Luxenberg, Deborah
    Askew, G. Roger
    Milarski, Kim L.
    Groves, Christopher
    Brown, Tom
    Carito, Brenda A.
    Percival, Karen
    Carreno, Beatriz M.
    Collins, Mary
    Marusic, Suzana
    JOURNAL OF NEUROIMMUNOLOGY, 2007, 182 (1-2) : 124 - 134
  • [17] Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer
    Yusof, Mohd Nazzary Mamat
    Chew, Kah Teik
    Kampan, Nirmala Chandralega
    Hafizz, Abdul Muzhill Hannaan Abdul
    Shafiee, Mohamad Nasir
    PLOS ONE, 2025, 20 (03):
  • [18] Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer
    Sun, W.
    Ma, K.
    Wang, X.
    Liu, Y.
    He, H.
    Guo, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1996 - S1996
  • [19] Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors
    Pinto, Navin
    Park, Julie R.
    Murphy, Erin
    Yearley, Jennifer
    McClanahan, Terri
    Annamalai, Lakshmanan
    Hawkins, Douglas S.
    Rudzinski, Erin R.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [20] Expression of PD-L1, PD-L2 and PD-1 in thymic epithelial tumours (TETs).
    Gennatas, Spyridon
    Fernandez, Angeles Montero
    Bowman, Alex
    Ronquillo, John
    Nicholson, Andrew G.
    Popat, Sanjay
    Bowcock, Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345